Conviction
$ Value
$62K
Shares
6,500
Price
$10
Filed
Sep 16
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ 10%+ owner (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Lee Tien-Li
Title
Chief Executive Officer
CIK
0001940120
Roles
Transaction Details
Transaction Date
2025-09-15
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,539,884
Footnotes
The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.9045 to $9.89 per share, inclusive. The reporting person undertakes to provide Aardvark Therapeutics, Inc. ("Aardvark"), any security holder of Aardvark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.93 to $9.9798 per share, inclusive. The reporting person undertakes to provide Aardvark, any security holder of Aardvark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Filing Info
Lee Tien-Li's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-09 | AARD | A | $0 |
| 2025-12-11 | AARD | ▲ | $101K ★ |
| 2025-10-15 | AARD | M | $5K |
| 2025-10-15 | AARD | M | $0 |
| 2025-09-15 | AARD | ▲ | $62K |
| 2025-09-15 | AARD | ▲ | $35K |
| 2025-09-12 | AARD | ▲ | $43K |
| 2025-09-11 | AARD | ▲ | $47K |
| 2025-09-10 | AARD | ▲ | $71K |
| 2025-08-28 | AARD | M | $73K |
Other Insiders at AARD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Lee Tien-Li
Chief Executive Officer
|
— | — | 2026-02-09 |
|
Sun Nelson
Chief Financial Officer
|
— | — | 2026-02-09 |
|
Jaiman Manasi
Chief Medical Officer
|
— | — | 2026-02-09 |